Oct 6, 20261 hour
In this special in-person episode, recorded in San Diego, we sit down with Melody Shahsavarian, Senior Director of Data Strategy and Digital Transformation at Eli Lilly. Before Lilly, she led NGS and AI for biologics...
business
Models & Molecules
Hosted by enpicom · business · EN
About this Podcast:
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow.Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators.Produced by ENPICOM , Models & Molecules offers a rare look behind the buzzwords of AI-driven discovery, uncovering the practical realities, lessons learned, and moments of insight that emerge when biology meets computation.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
28%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for Models & Molecules.
Signup to Generate a PitchQuestions about Models & Molecules
What is Models & Molecules about?
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow. Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators.
What has Models & Molecules covered recently?
Recent episodes include "Melody Shahsavarian | Agentic AI and the Digital Transformation of Pharma R&D" (6 October 2026, 60 minutes), "Talip Uçar | Inside Boltz's open-source bet on the future of AI-driven drug discovery" (2 June 2026, 45 minutes), and "Steve Comeau | From novel binder design to the realities of AI in complex therapeutics" (14 April 2026, 46 minutes).
How often does Models & Molecules publish?
Models & Molecules publishes roughly monthly, with episodes averaging 49 minutes across 8 episodes.
How hard is it to get booked on Models & Molecules?
Booking probability for Models & Molecules is 28%, and the host is rated Selective on guests. Models & Molecules requires a Pod Score of 80 or higher. Models & Molecules's contact route on record: verified email.
Who should pitch Models & Molecules?
The strongest fits for Models & Molecules are Scientific Research & Development. Models & Molecules has a business audience.
About the host
Models & Molecules is a business podcast with 8 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Models & Molecules
Talip Uçar | Inside Boltz's open-source bet on the future of AI-driven drug discovery
Jun 2, 202645 minS0<p>When an AI model generates an image, you can tell at a glance whether it's any good. In life sciences, that feedback loop is fragmented across data, modelling, experiments, and the clinic, and signal gets lost at...
Models & Molecules
Steve Comeau | From novel binder design to the realities of AI in complex therapeutics
Apr 14, 202646 minS0<p>Generative models can now propose novel antibody sequences from antigen structure alone, but how far does that actually get you? In this episode, we sit down with Principal Scientist Steve Comeau to discuss what...
- Mar 3, 202646 minS0
<p>Jiwon Kim, Product Lead at AWS AI Life Sciences, joins Models & Molecules to break down pharma’s digital shift: where cloud and software are becoming core infrastructure for modern drug discovery. </p><p>We touch...
Models & Molecules
Do Soon Kim | Navigating the convergence of tech and pharma
Jan 28, 202646 minS0<p>In this episode of Models & Molecules, Do Soon Kim, Head of Product at Xaira Therapeutics, discusses his journey in the biotech and AI sectors, emphasizing the importance of effective communication in fostering...
View More
- Dec 16, 202555 minS0
<p>In this episode of Models & Molecules, Jaap Goudsmit, MD, PhD, immunologist, epidemiologist, and one of the scientific forces behind Crucell, the Dutch biotech acquired by Johnson & Johnson, explores the critical...
Models & Molecules
René Hoet | Taking risks and driving innovation in biopharma
Nov 4, 202543 minS0<p>In this episode of Models & Molecules, René Hoet reflects on game-changing technologies like phenotypic screening, the unique innovation dynamics of small biotechs versus large pharma, and the real-world impact of AI...
Recent guests
Recent guests on Models & Molecules. Study who booked and why before you pitch.
T
Talip Uçar
Boltz
J
Jiwon Kim
AWS AI Life Sciences
D
Do Soon Kim
Xaira Therapeutics
J
Jaap Goudsmit
Crucell
Best industries to pitch Models & Molecules for
PitchCentric classifies Models & Molecules under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like Models & Molecules
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ